Bluebird Bio (NASDAQ: BLUE) reported Q2 EPS of ($2.13), $1.78 worse than the analyst estimate of ($0.35). Revenue for the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Earnings